250 related articles for article (PubMed ID: 12727570)
1. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Picozzi VJ; Kozarek RA; Traverso LW
Am J Surg; 2003 May; 185(5):476-80. PubMed ID: 12727570
[TBL] [Abstract][Full Text] [Related]
2. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Nukui Y; Picozzi VJ; Traverso LW
Am J Surg; 2000 May; 179(5):367-71. PubMed ID: 10930481
[TBL] [Abstract][Full Text] [Related]
3. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
[TBL] [Abstract][Full Text] [Related]
4. Interferon-based Adjuvant Chemoradiation for Resected Pancreatic Head Cancer: Long-term Follow-up of the Virginia Mason Protocol.
Rocha FG; Hashimoto Y; Traverso LW; Dorer R; Kozarek R; Helton WS; Picozzi VJ
Ann Surg; 2016 Feb; 263(2):376-84. PubMed ID: 25775069
[TBL] [Abstract][Full Text] [Related]
5. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759].
Knaebel HP; Märten A; Schmidt J; Hoffmann K; Seiler C; Lindel K; Schmitz-Winnenthal H; Fritz S; Herrmann T; Goldschmidt H; Krempien R; Mansmann U; Debus J; Diehl V; Büchler MW
BMC Cancer; 2005 Apr; 5():37. PubMed ID: 15826316
[TBL] [Abstract][Full Text] [Related]
6. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.
Spitz FR; Abbruzzese JL; Lee JE; Pisters PW; Lowy AM; Fenoglio CJ; Cleary KR; Janjan NA; Goswitz MS; Rich TA; Evans DB
J Clin Oncol; 1997 Mar; 15(3):928-37. PubMed ID: 9060530
[TBL] [Abstract][Full Text] [Related]
7. Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031.
Picozzi VJ; Abrams RA; Decker PA; Traverso W; O'Reilly EM; Greeno E; Martin RC; Wilfong LS; Rothenberg ML; Posner MC; Pisters PW;
Ann Oncol; 2011 Feb; 22(2):348-54. PubMed ID: 20670978
[TBL] [Abstract][Full Text] [Related]
8. Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up.
Ohman KA; Liu J; Linehan DC; Tan MC; Tan BR; Fields RC; Strasberg SM; Hawkins WG
HPB (Oxford); 2017 May; 19(5):449-457. PubMed ID: 28162923
[TBL] [Abstract][Full Text] [Related]
9. Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial.
Katz MH; Wolff R; Crane CH; Varadhachary G; Javle M; Lin E; Evans DB; Lee JE; Fleming JB; Pisters PW
Ann Surg Oncol; 2011 Dec; 18(13):3615-22. PubMed ID: 21701927
[TBL] [Abstract][Full Text] [Related]
10. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.
Pisters PW; Abbruzzese JL; Janjan NA; Cleary KR; Charnsangavej C; Goswitz MS; Rich TA; Raijman I; Wolff RA; Lenzi R; Lee JE; Evans DB
J Clin Oncol; 1998 Dec; 16(12):3843-50. PubMed ID: 9850029
[TBL] [Abstract][Full Text] [Related]
11. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
[TBL] [Abstract][Full Text] [Related]
12. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: a single-institution phase II study.
Linehan DC; Tan MC; Strasberg SM; Drebin JA; Hawkins WG; Picus J; Myerson RJ; Malyapa RS; Hull M; Trinkaus K; Tan BR
Ann Surg; 2008 Aug; 248(2):145-51. PubMed ID: 18650621
[TBL] [Abstract][Full Text] [Related]
14. Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703).
Thomas CR; Weiden PL; Traverso LW; Thompson T
Am J Clin Oncol; 1997 Apr; 20(2):161-5. PubMed ID: 9124192
[TBL] [Abstract][Full Text] [Related]
15. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma.
Schmidt J; Abel U; Debus J; Harig S; Hoffmann K; Herrmann T; Bartsch D; Klein J; Mansmann U; Jäger D; Capussotti L; Kunz R; Büchler MW
J Clin Oncol; 2012 Nov; 30(33):4077-83. PubMed ID: 23008325
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
White R; Lee C; Anscher M; Gottfried M; Wolff R; Keogan M; Pappas T; Hurwitz H; Tyler D
Ann Surg Oncol; 1999; 6(1):38-45. PubMed ID: 10030414
[TBL] [Abstract][Full Text] [Related]
17. Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas.
Lee JH; Whittington R; Williams NN; Berry MF; Vaughn DJ; Haller DG; Rosato EF
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):945-53. PubMed ID: 10863064
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer.
Magnin V; Moutardier V; Giovannini MH; Lelong B; Giovannini M; Viret F; Monges G; Bardou VJ; Alzieu C; Delpero JR
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1300-4. PubMed ID: 12654441
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer.
Penberthy DR; Rich TA; Shelton CH; Adams R; Minasi JS; Jones RS
Ann Oncol; 2001 May; 12(5):681-4. PubMed ID: 11432628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
